Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization
- Status
- WITHDRAWN
- Phase
- NA
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC
- Status
- COMPLETED
- Phase
- N/A
REgistry of Selective Internal Radiation Therapy in TaiwaN (RESIN)
- Status
- UNKNOWN
- Phase
- N/A
Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Observation Study: Superselective Drug-Eluting Chemoembolization in Unresectable Intermediate and Advanced HCC Patients
- Status
- UNKNOWN
- Phase
- N/A
Emulsion Versus Suspension in Chemoembolization for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Combination of TATE and PD-1 Inhibitor in Liver Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin
- Status
- COMPLETED
- Phase
- PHASE1
Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response
- Status
- COMPLETED
- Phase
- N/A
Impact of Y90 Radiation Segmentectomy on HCC
- Status
- COMPLETED
- Phase
- NA
Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Targeted and Staged Cyber Knife Combined With Interventional Therapy in the Treatment of MHCC
- Status
- UNKNOWN
- Phase
- NA
Cytidine-phosphate-guanosine (CpG) DNA in Hepatocellular Carcinoma Combination Therapy
- Status
- UNKNOWN
- Phase
- PHASE1
Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry
- Status
- COMPLETED
- Phase
- N/A
A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)
- Status
- COMPLETED
- Phase
- N/A
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
MicroRNAs as Diagnostic Biomarkers in Hepatocellular Carcinoma Among Somali Patients
- Status
- UNKNOWN
- Phase
- N/A
Nivolumab With or Without Ipilimumab in Treating Patients With Resectable Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2